CVE:MPH Medicure (MPH) Stock Price, News & Analysis C$1.10 0.00 (0.00%) As of 05/22/2026 10:37 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Medicure Stock (CVE:MPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Medicure alerts:Sign Up Key Stats Today's RangeC$1.10▼C$1.1050-Day RangeC$0.90▼C$1.3552-Week RangeC$0.85▼C$1.43Volume7,066 shsAverage Volume2,796 shsMarket CapitalizationC$11.48 millionP/E RatioN/ADividend Yield2.24%Price TargetN/AConsensus RatingN/A Company Overview Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. Read More Receive MPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MPH Stock News HeadlinesMedicure (CVE:MPH) Stock Passes Above Fifty Day Moving Average - Time to Sell?May 21, 2026 | americanbankingnews.comMedicure Inc. (MPH:CA) Q4 2025 Earnings Call Prepared Remarks TranscriptApril 27, 2026 | seekingalpha.comOne page of the SpaceX S-1 will move this stock overnightWhen SpaceX files its S-1 in June, the SEC will require full disclosure of operating expenses - including power consumption for 1 million GPUs, a cost that rivals entire cities. That disclosure will name the supplier. One small, publicly traded power infrastructure company sits at the center of this - carrying a $1.5 billion backlog and priced like a utility. Dylan Jovine has the full breakdown. | Behind the Markets (Ad)Medicure, Inc.: Medicure Reports Financial Results for the Year Ended December 31, 2025 and Schedules April 27, 2026 Conference CallApril 24, 2026 | finanznachrichten.deMedicure's president and COO, Neil Owens to resign; CEO Albert Friesen to take over presidential dutiesApril 20, 2026 | msn.comMedicure, Inc.: Medicure Announces Resignation of President and Chief Operating OfficerApril 18, 2026 | finanznachrichten.deMedicure Inc. (MPH:CA) Q3 2025 Earnings Call TranscriptNovember 20, 2025 | seekingalpha.comMedicure Sees Revenue Growth Amidst Challenges in Q3 2025November 19, 2025 | msn.comSee More Headlines MPH Stock Analysis - Frequently Asked Questions How have MPH shares performed this year? Medicure's stock was trading at C$1.14 at the beginning of 2026. Since then, MPH shares have decreased by 3.5% and is now trading at C$1.10. How were Medicure's earnings last quarter? Medicure Inc. (CVE:MPH) released its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.37. The firm had revenue of $8.71 million for the quarter, compared to the consensus estimate of $14.50 million. Medicure had a negative trailing twelve-month return on equity of 44.51% and a negative net margin of 21.74%. How do I buy shares of Medicure? Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Medicure own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), Hudbay Minerals (HBM), ProMetic Life Sciences (PLI) and Athersys (ATHX). Company Calendar Last Earnings5/24/2017Today5/26/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:MPH CIKN/A Webwww.medicure.com Phone+1-204-4877412FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.68) Trailing P/E RatioN/A Forward P/E Ratio16.85 P/E GrowthN/ANet Income-C$2.03 million Net Margins-21.74% Pretax MarginN/A Return on Equity-44.51% Return on Assets-5.63% Debt Debt-to-Equity Ratio6.34 Current Ratio1.04 Quick Ratio1.29 Sales & Book Value Annual SalesC$28.86 million Price / Sales0.40 Cash FlowC$0.44 per share Price / Cash Flow2.49 Book ValueC$1.21 per share Price / Book0.91Miscellaneous Outstanding Shares10,436,000Free FloatN/AMarket CapC$11.48 million OptionableNot Optionable Beta0.62 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (CVE:MPH) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredTrump Admin to Pump $1 Billion into this “Off-the-Radar” AI StockThe U.S. government pumped more than $1 billion into Intel. The stock popped 128%. It pumped $400 million into...InvestorPlace | SponsoredGold surged 600 dollars last time this indicator peakedThe Buffett Indicator has predicted every major gold bull run this century - 2000, 2008, and 2020, when gold s...Porter & Company | SponsoredOpportunity Forming in a U.S. Supply-Chain Weak Spot?America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicure Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MPH with Qtrade Free MPH Stock Alerts